Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
TERT Promoter Variants, Older Age, and Prognosis in Papillary Thyroid Carcinoma.
Journal: JAMA otolaryngology-- head & neck surgery
Published: August 20, 2026
Revised Thyroid Differentiation Score for Risk Stratification in Papillary Thyroid Carcinoma.
Journal: JCO precision oncology
Published: July 23, 2026
Patient-Reported Symptom Burden Among Thyroid Cancer Survivors: Retrospective Cohort Study.
Journal: JCO clinical cancer informatics
Published: July 02, 2026
Lenvatinib plus pembrolizumab for the treatment of patients with non-BRAF mutated anaplastic thyroid cancer: A single center, phase 2 clinical trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 16, 2026
Designer indicators for two-photon recording of subthreshold voltage dynamics.
Journal: bioRxiv : the preprint server for biology
Published: April 17, 2026
Acquired Driver Fusions as a Mechanism of Resistance to Selective RET Inhibitors in Advanced Medullary Thyroid Carcinoma.
Journal: JCO precision oncology
Published: February 20, 2026
Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid Dysfunction.
Journal: JCO oncology practice
Published: December 19, 2025
A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.
Journal: Journal of neuro-oncology
Published: November 03, 2025
RET-driven osteoprotegerin expression links medullary thyroid cancer to osteoblastic bone metastases.
Journal: Cell reports. Medicine
Published: September 18, 2025
Prognostic Factors in Thyroid Cancer Patients With Brain Metastases: A Systematic Review and Meta-Analysis.
Journal: Thyroid : official journal of the American Thyroid Association
Published: September 16, 2025
Patient-Reported Tolerability of Selpercatinib Compared to Cabozantinib/Vandetanib: A Secondary Analysis of the LIBRETTO-531 Randomized-Controlled Trial in RET-Mutant Medullary Thyroid Cancer.
Journal: Thyroid : official journal of the American Thyroid Association
Published: August 19, 2025
Activating RET Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer.
Journal: bioRxiv : the preprint server for biology
Published: August 12, 2025
Last Updated: 09/26/2026